- Policy
- 55,000 doses of Mordena vaccines will be released in a week
- by Kim, Jung-Ju May 26, 2021 06:05am
- Moderna's 55,000 mRNA-like COVID-19 vaccines will arrive in Korea next Monday, or the 31st. The COVID-19 vaccine, developed by foreign pharmaceutical companies in Korea, is the third since AstraZeneca and Pfizer, and has been rapidly introduced since the signing of an MOU between health authorities and companies. The MOHW announced on t
- Company
- 1st reimb. discussion to start on 2 tumor-agnostic therapies
- by Eo, Yun-Ho May 25, 2021 06:04am
- Two types of tumor-agnostic therapies seek reimbursement listing in Korea. Industry sources say Roche Korea’s Neurotrophic tyrosine receptor kinase(NTRK) Rozlytrek (entrectinib) and Bayer Korea’s ‘Vitrakvi (larotrectinib)’ will be up for deliberation by the National Health Insurance Service's (NHIS) Cancer Drug Review Committee meeti
- Company
- Keytruda leads domestic market sales … Perjeta·Prolia also
- by Chon, Seung-Hyun May 25, 2021 06:03am
- The cancer immunotherapy ‘Keytruda’ firmly held its lead in the domestic pharmaceutical market. This is the 5th consecutive quarter from the first quarter of last year that the drug has recorded top sales among all pharmaceuticals in Korea. Also, the new biopharmaceuticals introduced by multinational pharmaceutical companies like ‘Perjeta,’
- Company
- Samsung Biologics, commissioned to produce Moderna vaccine
- by Kim, Jin-Gu May 25, 2021 06:03am
- Samsung BioLogics signed a contract with Moderna on the 22nd (local time) to commission the production of COVID-19 vaccines. After producing undiluted corona vaccine abroad, Samsung BioLogics will charge and pack it in Korea. Samsung BioLogics CEO John Lim and CEO St&233;phane Bancel Moderna attended the "Korea-U.S. Vaccine Company Coope
- Policy
- Moderna COVID-19 vaccine is finally licensed
- by Lee, Tak-Sun May 25, 2021 06:03am
- Moderna COVID-19 Vaccine has obtained a final item license in Korea. The MFDS announced on the 21st that GC Pharma has decided to permit imported items on the condition that it submits a final report on clinical trials for Moderna COVID-19 Vaccine, which it applied for permission for imported items on April 12. Moderna COVID-19 Vaccine
- Company
- Organon’s spinoff from MDS to be completed in June
- by Eo, Yun-Ho May 24, 2021 05:51am
- Organon’s spinoff from MSD will soon be complete. Industry sources expect the administrative spin-off at the global headquarters of MSD and Organon to be completed within the next month (June). Following the spinoff, Organon & Co. will launch as a completely independent corporation in Korea as well. Organon’s Korean subsidiary has al
- Product
- Zuellig Pharma ends distribution at the end of this month
- by May 24, 2021 05:51am
- Zuellig Pharma Korea, a global drug distribution company, announced its order and return procedures to prevent confusion as of this month. According to pharmacies on the 24th, Zuellig Pharma Korea recently announced a re-announcement of the termination of the pharmacy distribution business to pharmacies and others. Although it has alrea
- Company
- Tagrisso's 1st-line reimb. necessary based on its OS benefit
- by May 24, 2021 05:51am
- With ‘Tagrisso (osimertinib)’ winning recognition as the first-line standard treatment for epidermal growth factor receptor (EGFR)-mutated advanced and metastatic non-small cell lung cancer, the demand for its reimbursement as first-line in Korea has also been increasing. At the Lung Cancer 1 session of the 19th Annual Symposium & Gener
- Policy
- National Assembly is paying attention to news of AZ-Pfizer's
- by Lee, Jeong-Hwan May 24, 2021 05:50am
- Overseas studies have shown that the second shot of the Pfizer-Biontech vaccine after the first shot of the COVID-19 vaccine developed by AstraZeneca (AZ) and Oxford University is effective and safe. The National Assembly also seems to be interested in responding to domestic quarantine authorities regarding cross-vaccination. Based on oversea
- Policy
- 438,000 doses of Pfizer Vaccines are received on the 19th
- by Lee, Jeong-Hwan May 24, 2021 05:50am
- On the 19th, an additional 438,000 doses of COVID-19 vaccine, which South Korea directly contracted with Pfizer, will arrive in South Korea. It is part of the 7 million units that are scheduled to be supplied in the first half of the year, which are received in small quantities every week. Lee Sang-won, head of the Central Disease Control
